Compare ARK Genomic Revolution ETF (ARKG) vs Kaltura Inc (KLTR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Kaltura Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Kaltura Inc trades at $1.25 (market cap $191.73M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Kaltura Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | KLTR | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $1.97 |
52-Week Low | $23.09 | $1.08 |
Market Cap | — | $191.73M |
Enterprise Value | — | $174.45M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Kaltura (KLTR) trades at $1.28, up 0.79% with a bearish technical outlook despite recent earnings beats. The company shows improving fundamentals with revenue stabilizing around $180M and net losses narrowing from -$68M in 2022 to -$12M in 2025. Recent industry recognitions highlight Kaltura's leadership in AI-powered digital engagement platforms, though negative ROE and high P/B ratio of 41.29 indicate valuation concerns.
While Kaltura demonstrates operational improvement and strong industry positioning, the stock faces headwinds from persistent losses and bearish technical signals. The mixed analyst sentiment (44% buy, 33% hold, 22% sell) reflects uncertainty about profitability timeline. Investment appeal hinges on the company's ability to convert AI innovation into sustainable earnings growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Kaltura Inc
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments: (i) Enterprise, Education, and Technology (EE&T)
Read more on KLTR →
